Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 05ZAGREB525, HIV/AIDS IN CROATIA: GOC FULLY FUNDS DRUG THERAPY

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05ZAGREB525.
Reference ID Created Released Classification Origin
05ZAGREB525 2005-04-01 07:19 2011-08-25 00:00 UNCLASSIFIED Embassy Zagreb
This record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS  ZAGREB 000525 
 
SIPDIS 
 
 
PLEASE PASS ESTH OFFICER 
DEPARTMENT FOR S/GAC AND EUR/PGI/BRETT POMAINVILLE 
BUDAPEST FOR KARYN POSNER-MULLEN 
 
E.O. 12958: N/A 
TAGS: KHIV PHUM PGOV HR
SUBJECT: HIV/AIDS IN CROATIA: GOC FULLY FUNDS DRUG THERAPY 
DESPITE HIGH COSTS 
 
REF: (A) 04 ZAGREB 2171 (B) ZAGREB 0036 
 
SUMMARY AND COMMENT 
-------------------- 
 
1.  The GoC currently spends approximately $2 million per 
year to provide anti-retroviral drug (ARV) therapy to 218 
individuals known to be living with AIDS in Croatia.  Funding 
drug therapy is the GoC's primary contribution to the fight 
against HIV/AIDS; fortunately, the Global Fund has covered 
budget shortfalls for education and outreach.  Only top-end 
designer ARV drugs are available on the Croatian market; as a 
result, prices are high both by local and EU standards. 
Nonetheless, the national health insurance system thus far 
has been able to provide drug therapy whenever necessary.  So 
long as the number of cases remains small, two possible 
cost-saving measures -- importing generics or building a 
regional drug market -- have been slow to attract GoC 
attention. 
 
2.  This is the last in a series of three cables looking at 
HIV/AIDS in Croatia.  A snapshot of the current situation and 
Croatia's National Action Plan on HIV/AIDS (ref A) and a 
report on Global Fund efforts to expand free, anonymous 
testing (ref B) were reported reftel.  END SUMMARY AND 
COMMENT. 
 
DRUG TREATMENT TOPS THE LIST OF PRIORITIES 
------------------------------------------ 
 
3.  Ensuring continuity of care for the 218 individuals in 
Croatia known to be living with AIDS is a top priority of the 
2003-5 National Action Plan on HIV/AIDS.  ARV drug therapy 
costs approximately 5,000 kuna per patient per month 
(approximately $10,000 per year) depending on the drug 
combination used.  The national health insurance system 
treats ARV drugs just like any others with no separate budget 
for HIV/AIDS treatment.  The total cost of ARV treatment is 
approximately $2 million per year.  All drugs are prescribed 
and delivered through the Zagreb Clinic for Infectious 
Diseases -- patients have no co-financing requirement and are 
only required to appear in person in Zagreb to receive drugs. 
 The Clinic has special programs to provide drugs to 
prisoners and asylum seekers who are unable to appear in 
person at the Clinic.  In addition to providing drug therapy, 
the insurance system also finances counseling services and 
long-term case management.  The Ministry of Health maintains 
a far smaller budget (less than 5% of total HIV/AIDS 
expenditure) for prevention programs. 
 
REGISTRATION HARDLY COST EFFECTIVE FOR DEVELOPERS 
--------------------------------------------- ---- 
 
4.  New antiretroviral drug treatments -- like all new drugs 
-- must be licensed by the Ministry of Health before they can 
be prescribed.  Fourteen ARV drugs (produced by GSK, MSD, 
Abbot, Roche, Boehringer, and Bristol Myers Squibb) have 
already been licensed.  The national health insurance system 
maintains a separate list of drugs approved for tax 
exemption; thirteen ARV drugs are already tax-exempt, while 
the insurance system is in negotiations directly with the 
manufacturer on offering the last licensed drug tax-free. 
Croatia's leading immunologist and Vice President of the 
National HIV/AIDS Committee Dr. Josip Begovac criticized the 
slow procedure for registering new drugs and expressed hope 
that the GoC would eventually accept EU licensing rather than 
requiring a separate national procedure.  Ministry of Health 
officials conceded that developers have little financial 
incentive to register new ARVs on the Croatian market -- the 
registration process is cumbersome and expensive and the 
potential payoff is small given the small domestic market for 
ARV drug therapy.  Croatian law also allows for case-by-case 
approval of unlicensed drugs in certain emergency situations; 
forty AIDS patients are currently received drug treatment 
under this provision. 
 
LITTLE INTEREST IN COST-CUTTING PROSPECTS 
----------------------------------------- 
 
5.  Two proposals -- importing generic ARV drugs or 
collaborating with BiH and SaM on a regional drug market -- 
might have the potential to depress high drug prices, but so 
long as the health insurance system can afford care the GoC 
has little interest in pursuing either option.  Importing 
generics has never been seriously considered by health 
professionals, since the GoC has never complained about high 
drug costs.  Begovac also noted WHO concerns about the safety 
of certain ARV generics from India as well as concern by 
national pharmaceutical giant Pliva about establishing a 
precedent of importing cheaper generics.  Regarding a 
 
 
regional drug market, the small size of the Bosnian ARV 
market means SaM is the only possible partner for Croatia to 
join with to negotiate down drug prices.  GoC health 
officials are skeptical that even an expanded market of 1,000 
cases would translate into enough savings to justify dealing 
with the "hectic" health situation in Belgrade.  According to 
Begovac, "Croatians are used to a high quality of health care 
-- it is an accepted right that is not going to change 
easily." 
 
6.  This cable was coordinated with U.S. Embassies Sarajevo 
and Belgrade. 
DELAWIE 
 
 
NNNN